BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Böhme R, Becker C, Keil B, Damm M, Rasch S, Beer S, Schneider R, Kovacs P, Bugert P, Riedel J, Griesmann H, Ruffert C, Kaune T, Michl P, Hesselbarth N, Rosendahl J. Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitis. Pancreatology 2020;20:187-192. [DOI: 10.1016/j.pan.2019.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kuzan A, Królewicz E, Kustrzeba-Wójcicka I, Lindner-Pawłowicz K, Sobieszczańska M. How Diabetes and Other Comorbidities of Elderly Patients and Their Treatment Influence Levels of Glycation Products. Int J Environ Res Public Health 2022;19:7524. [PMID: 35742776 DOI: 10.3390/ijerph19127524] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Chen L, Dai L, Liu Y, Li X, Wang H. Yiqi Huoxue Recipe Regulates Autophagy through Degradation of Advanced Glycation End Products via mTOR/S6K1/LC3 Pathway in Diabetic Nephropathy. Evid Based Complement Alternat Med 2021;2021:9942678. [PMID: 34408785 DOI: 10.1155/2021/9942678] [Reference Citation Analysis]
3 Porozan S, Alavinejad P, Mozafari J, Kazem Mousavi H, Delirrooyfard A. Serum Level of Galectin-3 in Early Detection of Acute Pancreatitis. Middle East J Dig Dis 2021;13:350-5. [DOI: 10.34172/mejdd.2021.246] [Reference Citation Analysis]
4 Jaisson S, Gillery P. Methods to assess advanced glycation end-products. Curr Opin Clin Nutr Metab Care 2021;24:411-5. [PMID: 34155155 DOI: 10.1097/MCO.0000000000000774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Srejovic IM, Lukic ML. Galectin-3 in T cell-mediated immunopathology and autoimmunity. Immunol Lett 2021;233:57-67. [PMID: 33753135 DOI: 10.1016/j.imlet.2021.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]